Historically, these studies represent initial significant contributions to the emerging research discipline of cancer immunology that offered the first valuable insights into differential FAP expression in normal tissues, malignant tissues, and cultured cells, paving the way for future therapeutic development involving the F19 mAb and its derivatives. This evidence concerns the gene FAP and cancer.